Artificial intelligence is rapidly being adopted across healthcare systems in the European Union, improving diagnostics and patient engagement, but WHO warns that governance and safety frameworks are still lagging behind.

Glimpse:

According to a 2026 WHO/Europe report, AI is now widely used across EU healthcare systems, with 74% of countries using AI-assisted diagnostics and 63% deploying AI chatbots for patient interaction. However, the report highlights gaps in regulation, workforce readiness, and safety oversight, emphasizing the need for stronger governance and standardized frameworks.

Artificial intelligence is gaining significant traction across healthcare systems in the European Union, according to a new report by WHO/Europe that provides the first comprehensive snapshot of AI adoption across member states.

The report reveals that AI is already embedded in many aspects of healthcare delivery. Around 74% of EU countries are using AI tools for diagnostics, including medical imaging, disease detection, and clinical decision support. Additionally, 63% of countries have implemented AI-powered chatbots to enhance patient engagement and communication.

AI is also being used to streamline administrative workflows, reduce clinician workload, and improve efficiency in healthcare systems. These applications are helping reduce waiting times, enhance accuracy in diagnosis, and support better patient outcomes.

Despite this rapid growth, the WHO report raises concerns about uneven readiness across countries. While many nations have adopted AI tools, fewer have robust frameworks in place for governance, regulation, and ethical oversight. Key gaps remain in areas such as data governance, interoperability, workforce training, and risk management.

The report also highlights that less than half of EU countries have dedicated AI roles or structured training programs, indicating a shortage of skilled professionals needed to manage and scale AI solutions effectively.

To address these challenges, WHO emphasizes the importance of strong regulatory frameworks, transparency, and human oversight, especially since healthcare AI is classified as a high risk domain under the EU AI Act.

The findings underline a critical balance: while AI has the potential to transform healthcare delivery and improve outcomes, its safe and equitable implementation requires coordinated policy efforts, investment in workforce development, and standardized evaluation mechanisms.

Overall, the report reflects a broader shift toward AI-driven healthcare in Europe one that is accelerating rapidly but must be carefully managed to ensure patient safety, trust, and long term sustainability.